You are here

  • Home
  • Archive
  • Volume 4, Issue Suppl 1
  • 185 Serum tumourtumor necrosis (TNF)-like weak inducer of apoptosis (TWEAK) and leptin as biomarkers of accelerated atherosclerosis in patients with systemic lupus erythematosus and antiphospholipid syndrome

Article info

Article menu

Download PDFPDF

Poster Session
SLE Complications and comorbidities
185 Serum tumourtumor necrosis (TNF)-like weak inducer of apoptosis (TWEAK) and leptin as biomarkers of accelerated atherosclerosis in patients with systemic lupus erythematosus and antiphospholipid syndrome
Free

Authors

Citation

Mostafa E, badawi A
185 Serum tumourtumor necrosis (TNF)-like weak inducer of apoptosis (TWEAK) and leptin as biomarkers of accelerated atherosclerosis in patients with systemic lupus erythematosus and antiphospholipid syndrome
Lupus Science & Medicine 2017;4:doi: 10.1136/lupus-2017-000215.185

Publication history

  • First published March 24, 2017.
Online issue publication 
March 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions